Rodin Therapeutics

Rodin Therapeutics is a biotechnology company discovering and developing first in class therapeutics for neurological disorders. The Company applies unique insights into the role of epigenetics and novel chemical strategies to target specific HDAC complexes.
TypeSubsidiary
Parent CompanyAlkermes
HQBoston, MA, US
Founded2013
Websiterodintherapeutics.com
Cybersecurity ratingAMore
Rodin Therapeutics was founded in 2013 and is headquartered in Boston, MA, US

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Rodin Therapeutics

Adam Rosenberg

Adam Rosenberg

CEO

Rodin Therapeutics Office Locations

Rodin Therapeutics has an office in Boston
Boston, MA, US (HQ)
101 Huntington Avenue, 101 Huntington Ave 21st Floor, Suite 2150
Show all (1)

Rodin Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2013

Total Funding

$57.2 m

Investors

In total, Rodin Therapeutics had raised $57.2 m. Rodin Therapeutics is a subsidiary of Alkermes

Rodin Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

Rodin Therapeutics Online and Social Media Presence

Embed Graph

Rodin Therapeutics News and Updates

Rodin Therapeutics Expands Leadership Team, Adding Extensive Experience in Clinical and Business Development

PRESS RELEASE: Rodin Therapeutics today announced the appointments of three senior executives with extensive experience in clinical and business development as well as a senior scientific advisor to focus on pipeline strategy. With their strong backgrounds...

Rodin Therapeutics Blogs

Rodin Therapeutics Applies Insights of Epigenetics to Neurological Disorders

CAMBRIDGE, MA – Rodin Therapeutics, a biotechnology company applying insights of epigenetics to novel therapeutics for neurological disorders, announced its founding by Atlas Venture and Proteros biostructures. Rodin is founded based on its insight into key epigenetic modulators of CNS… The post Rod…

Neurological Disorders: 5 Symptoms You Must Not Ignore

Many aspects of the human body leave even the doctors and scientists perplexed so much so that fund is often raised for the research of a new subject. The evolving medicine sector has paved the path to a healthier future,… The post Neurological Disorders: 5 Symptoms You Must Not Ignore appeared firs…

Rodin Therapeutics Announces Publication of Paper Demonstrating Pro-Synaptic Effects of CoREST-Selective Inhibitors

CAMBRIDGE, Mass. – December 5, 2018 – Rodin Therapeutics today announced the publication of a scientific paper demonstrating the efficacy of novel compounds which selectively inhibit the HDAC-CoREST complex. In preclinical models, the compounds promote synaptic growth and function while minimizing t…

Rodin Therapeutics Launches Clinical Trial of Neuroimaging Tool for Measurement of Synaptic Density

CAMBRIDGE, Mass., October 18, 2018 — Rodin Therapeutics today announced the launch of a clinical trial to assess the performance of a new PET ligand that can measure synaptic density in the living brain. Insights from the study will guide Rodin’s upcoming Phase 1b trial of a novel therapeutic compou…

Rodin Therapeutics Frequently Asked Questions

  • When was Rodin Therapeutics founded?

    Rodin Therapeutics was founded in 2013.

  • Who are Rodin Therapeutics key executives?

    Rodin Therapeutics's key executives are Adam Rosenberg.

  • How many employees does Rodin Therapeutics have?

    Rodin Therapeutics has 1 employees.

  • Who are Rodin Therapeutics competitors?

    Competitors of Rodin Therapeutics include Alembic Pharmaceuticals, EMS Pharma and Biocon.

  • Where is Rodin Therapeutics headquarters?

    Rodin Therapeutics headquarters is located at 101 Huntington Avenue, 101 Huntington Ave 21st Floor, Suite 2150, Boston.

  • Where are Rodin Therapeutics offices?

    Rodin Therapeutics has an office in Boston.

  • How many offices does Rodin Therapeutics have?

    Rodin Therapeutics has 1 office.